„Checkpoints“
Suchergebnisse
349 Treffer
-
CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints
-
Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia
-
PD-1/PD-L1 Pathway in Breast Cancer
-
Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance
-
Multiple defects of cell cycle checkpoints in U937-ASPI3K, an U937 cell mutant stably expressing anti-sense ATM gene cDNA
-
Working the Passage – East German Border Checkpoints, 1961–90. The Case of GÜSt Bahnhof Friedrichstraße, Berlin
-
Associations between HIFs and tumor immune checkpoints: mechanism and therapy
-
Genetically Engineered Macrophages Co‐Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury
-
The upregulation of immune checkpoints after photodynamic therapy reducing immune effect for treating breast cancer
-
DNA damage checkpoints in stem cells, ageing and cancer
-
Understanding immune checkpoints and PD-1/PD-L1-mediated immune resistance towards tumour immunotherapy
-
Increasing processor utilization in hard-real-time systems with checkpoints
-
Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy
-
High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints
-
Glycoproteomic landscape and structural dynamics of TIM family immune checkpoints enabled by mucinase SmE
-
The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
-
Nano‐Mediated PDT as a Multifunctional Immunomodulatory Agent in the Intricate Milieu of Melanoma
-
Soluble immune checkpoints are elevated in patients with primary biliary cholangitis
-
The kinetics of inhibitory immune checkpoints during and post-COVID-19: the knowns and unknowns
-
Immune Escape Mediated by Exosomal PD‐L1 in Cancer